AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,482 | -4.9% | 3,373 | +8.8% | 0.00% | 0.0% |
| Q2 2023 | $87,820 | +23.3% | 3,101 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $71,230 | -24.8% | 3,101 | -8.0% | 0.00% | 0.0% |
| Q4 2022 | $94,686 | -0.7% | 3,372 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $95,360 | +27.6% | 3,372 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $74,757 | -23.8% | 3,372 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $98,159 | -80.8% | 3,372 | -78.3% | 0.00% | -42.9% |
| Q4 2021 | $511,622 | -28.8% | 15,565 | 0.0% | 0.01% | -30.0% |
| Q3 2021 | $718,325 | -23.0% | 15,565 | -8.1% | 0.01% | -23.1% |
| Q2 2021 | $933,067 | +1064.2% | 16,931 | +990.9% | 0.01% | +1200.0% |
| Q1 2021 | $80,145 | +21.1% | 1,552 | +1.6% | 0.00% | 0.0% |
| Q4 2020 | $66,208 | +20.5% | 1,528 | -2.7% | 0.00% | 0.0% |
| Q3 2020 | $54,950 | -35.7% | 1,570 | -1.8% | 0.00% | -50.0% |
| Q2 2020 | $85,461 | +37.6% | 1,598 | -8.7% | 0.00% | +100.0% |
| Q1 2020 | $62,090 | -26.3% | 1,750 | -0.8% | 0.00% | 0.0% |
| Q4 2019 | $84,231 | +71.1% | 1,764 | +16.1% | 0.00% | 0.0% |
| Q3 2019 | $49,216 | -72.3% | 1,519 | -57.4% | 0.00% | -66.7% |
| Q2 2019 | $177,772 | -27.7% | 3,564 | -2.2% | 0.00% | -25.0% |
| Q1 2019 | $245,751 | +43.3% | 3,644 | -2.0% | 0.00% | +33.3% |
| Q4 2018 | $171,529 | -40.4% | 3,720 | -0.3% | 0.00% | -40.0% |
| Q3 2018 | $287,812 | -99.9% | 3,732 | -2.1% | 0.01% | 0.0% |
| Q2 2018 | $321,170,000 | +11.6% | 3,813 | +8.4% | 0.01% | +25.0% |
| Q1 2018 | $287,784,000 | +170186.4% | 3,519 | +19.0% | 0.00% | +100.0% |
| Q4 2017 | $169,000 | -15.5% | 2,957 | -1.1% | 0.00% | +100.0% |
| Q3 2017 | $200,000 | +37.0% | 2,989 | +5.5% | 0.00% | 0.0% |
| Q2 2017 | $146,000 | +17.7% | 2,832 | +33.1% | 0.00% | 0.0% |
| Q1 2017 | $124,000 | +39.3% | 2,127 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $89,000 | -17.6% | 2,127 | +4.5% | 0.00% | 0.0% |
| Q3 2016 | $108,000 | +21.3% | 2,036 | -4.6% | 0.00% | 0.0% |
| Q2 2016 | $89,000 | +12.7% | 2,134 | +10.2% | 0.00% | 0.0% |
| Q1 2016 | $79,000 | -37.3% | 1,937 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $126,000 | -5.3% | 1,937 | +2.8% | 0.00% | 0.0% |
| Q3 2015 | $133,000 | -36.4% | 1,885 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $209,000 | -80.5% | 1,885 | -83.4% | 0.00% | -87.5% |
| Q1 2015 | $1,073,000 | -12.8% | 11,376 | +3.6% | 0.01% | -11.1% |
| Q4 2014 | $1,230,000 | +87.5% | 10,980 | +2.6% | 0.01% | +80.0% |
| Q3 2014 | $656,000 | +33.9% | 10,699 | 0.0% | 0.01% | +66.7% |
| Q2 2014 | $490,000 | +100.8% | 10,699 | +71.6% | 0.00% | +50.0% |
| Q1 2014 | $244,000 | +8.9% | 6,234 | -22.3% | 0.00% | 0.0% |
| Q3 2013 | $224,000 | – | 8,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |